MicroRNAs: Potential Biomarkers and Therapeutic Targets for Alzheimer's Disease

Recent studies have highlighted the potential of microRNAs (miRs) as both diagnostic biomarkers and targets for novel therapies in Alzheimer's disease (AD). These small, non-coding RNA molecules are increasingly recognized for their regulatory roles in various biological processes. Accumulating evidence suggests that dysregulation of specific miRs is linked to AD pathogenesis, influencing amyloid-beta accumulation, tau hyperphosphorylation, and neuronal dysfunction. This connection to key pathological hallmarks positions miRs as promising candidates for early disease detection and targeted interventions in AD.